Evidence map›Paper›PMID 20306302›Full record

ArticleMolecular biology reports2011

The role of cell cycle-dependent neuropathy target esterase in cell proliferation.

Ping-An Chang, Yu-ying Chen, Wen-zhen Qin, Ding-Xin Long, Yi-Jun Wu

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ping-An ChangKey Laboratory of Molecular Biology, College of Bio-Information, Chongqing University of Posts and Telecommunications, Chongqing, 400065, People's Republic of China. changpingan@yahoo.com.cn
Yu-ying Chen
Wen-zhen Qin
Ding-Xin Long
Yi-Jun Wu
Chongqing University of Posts and Telecommunications · CNInstitute of Zoology · CNFirst Affiliated Hospital of Xiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropathy target esterase (NTE) is a novel phospholipase B and plays a role in phospholipid homeostasis. Although over-expression of NTE inhibits cell division, the role of NTE in cell proliferation is still unknown. In the current study, we firstly used synchronous HeLa cells to study the expression profile of NTE during the cell cycle. NTE protein and activity are regulated during the cell cycle with highest level at G1 and lowest at G2/M phase. However, NTE mRNA levels are constant during the cell cycle. The role of NTE in cell proliferation was investigated by short hairpin RNA (shRNA) to suppress the expression of NTE. Knockdown of NTE significant down-regulated of NTE expression and reduced the glycerophosphocholine level. However, suppression of NTE did not affect phosphatidylcholine content or cell cycle progression. In addition, NTE was demonstrated to be degraded by the ubiquitin-proteasome pathway. These results suggested for the first time that NTE is a cell cycle-dependent protein, but is not essential for cell proliferation, and the ubiquitin-mediated proteolysis may be involved in the regulation of NTE during the cell cycle.

Indexed as

Cell CycleCarboxylic Ester HydrolasesCell Cycle ProteinsCell ProliferationGene Knockdown TechniquesGlycerylphosphorylcholineHeLa CellsHumansProteasome Endopeptidase ComplexProtein Processing, Post-TranslationalRNA, MessengerRNA, Small InterferingSignal TransductionUbiquitinCarboxylic Ester HydrolasesCell Cycle ProteinsGlycerylphosphorylcholineneurotoxic esteraseProteasome Endopeptidase ComplexRNA, MessengerRNA, Small InterferingUbiquitin

Identifiers

PMID20306302
OpenAlexW2049995626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.